Equities

Helius Medical Technologies Inc

Helius Medical Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.565
  • Today's Change-0.003 / -0.53%
  • Shares traded74.85k
  • 1 Year change-91.29%
  • Beta1.7287
Data delayed at least 15 minutes, as of Nov 11 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

  • Revenue in USD (TTM)594.00k
  • Net income in USD-8.84m
  • Incorporated2018
  • Employees22.00
  • Location
    Helius Medical Technologies Inc642 Newtown Yardley RoadNEWTOWN 18940United StatesUSA
  • Phone+1 (215) 944-6100
  • Fax+1 (302) 655-5049
  • Websitehttps://heliusmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Escalon Medical Corp11.98m-176.93k1.11m40.00--0.9551--0.0928-0.0239-0.02391.620.2442.384.276.34299,537.80-2.49-1.31-5.51-2.8842.9543.60-1.05-0.64431.04-5.030.1457---1.634.47-179.87--12.74--
Arch Therapeutics Inc148.17k-12.99m1.11m8.00------7.51-3.69-3.690.0383-2.830.100.0662--18,521.25-828.03-188.28---804.6339.58---8,276.08-26,945.920.0051-1.32----383.83---32.35---21.76--
Fuse Medical Inc18.40m3.63m1.18m31.000.4447--0.32060.06420.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Leafbuyer Technologies Inc5.43m-959.15k1.31m14.00------0.2415-0.0096-0.00960.0545-0.01793.64--41.85387,721.40-64.23-62.47----35.2333.53-17.67-62.40---6.34----33.7235.17-161.23------
Catheter Precision Inc436.00k-9.49m1.34m14.00--0.0253--3.07-12.95-12.950.604618.900.01410.55743.8931,142.86-30.71---33.63--92.20---2,176.84--0.098--0.0434--3,057.14---165.67------
Nu-Med Plus Inc0.00-112.13k1.49m2.00---------0.0014-0.00140.00-0.00220.00----0.00-471.23-447.69---------------21.34--------3.56------
Helius Medical Technologies Inc594.00k-8.84m1.82m22.00--0.2866--3.06-10.68-10.680.50421.980.06060.74864.4827,000.00-90.17-98.37-110.33-143.5712.7937.27-1,487.54-1,580.663.80--0.00---18.176.1437.11---41.95--
Tenon Medical Inc3.37m-13.87m1.88m21.00------0.5582-39.79-39.799.451.760.42522.275.27160,571.40-174.87---495.99--60.32---411.27--1.02--0.00--323.73--17.63------
Avinger Inc7.43m-15.34m1.90m68.00--0.2051--0.2564-12.13-12.135.834.050.4341.238.03109,250.00-113.20-70.93-1,387.68-131.5719.9630.87-260.86-208.911.20-11.660.3428---7.51-0.673632.76---24.21--
SINTX Technologies Inc3.13m-8.60m2.16m43.00--0.2445--0.6909-271.52-271.5216.4411.820.18181.777.6372,697.67-50.01-45.71-62.67-57.3667.7258.47-275.14-681.801.79--0.0265--68.2994.2449.75--54.10--
Telesis Bio Inc16.28m-50.12m2.25m137.00------0.1383-29.66-30.689.615.610.19473.153.40118,832.10-57.15---64.21--49.47---293.54--1.72-52.960.356--0.2697---1.14------
NanoVibronix Inc3.37m-2.82m2.44m10.00--0.6361--0.722-1.32-1.321.501.020.70810.43112.05337,300.00-59.12-116.16-122.41-169.3664.5750.47-83.49-570.471.16-14.770.00--203.5948.3331.88---34.02--
HeartSciences Inc18.60k-7.29m2.44m15.00--0.4079--131.11-5.65-5.650.00116.550.00350.0092--1,240.00-135.14---193.38--67.31---39,193.76--4.02-20.720.0777--261.17---3.95------
Acutus Medical Inc12.16m-5.82m2.44m233.00------0.2009-0.19650.69660.413-0.16390.17911.321.4452,184.55-8.58-46.76-11.07-56.88-13.40-89.12-47.89-773.491.88-3.391.18--136.3627.03-141.35---35.99--
Tivic Health Systems Inc1.11m-6.75m2.51m9.00--0.5987--2.26-4.33-4.330.54690.67790.23730.915676.76123,666.70-143.94---176.98--27.85---606.47--6.59--0.00---36.09--18.34------
Data as of Nov 11 2024. Currency figures normalised to Helius Medical Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

5.10%Per cent of shares held by top holders
HolderShares% Held
Armistice Capital LLCas of 30 Jun 2024130.00k3.64%
G1 Execution Services LLCas of 30 Jun 202416.26k0.46%
Geode Capital Management LLCas of 30 Jun 202414.61k0.41%
The Vanguard Group, Inc.as of 30 Jun 202412.60k0.35%
Tower Research Capital LLCas of 30 Jun 20246.90k0.19%
UBS Securities LLCas of 30 Jun 20241.55k0.04%
Corecap Advisors LLCas of 30 Sep 2024200.000.01%
Osaic Wealth, Inc. (Investment Management)as of 30 Jun 202480.000.00%
Desjardins Securities, Inc.as of 30 Jun 202437.000.00%
American Capital Advisory LLCas of 30 Sep 202431.000.00%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.